Concentra has appointed Tanner Newton executive vice president and chief financial officer, effective 1 November 2026. The occupational health company, which is headquartered in the Dallas area and trades on the New York Stock Exchange under the ticker CON, announced the appointment on 8 September 2026 in a news release and in a filing with the Securities and Exchange Commission.
Newton is currently senior vice president of strategy and finance at Concentra. In the wider role he will lead the company finance organisation, with responsibility for accounting, financial reporting, financial planning and analysis, treasury, tax, capital markets, corporate development and investor relations. He will continue to report to Matt DiCanio, currently president and chief financial officer, who becomes president and chief executive officer on the same date, so the finance function passes across in an orderly transition rather than to an outside hire.
The company had signalled the move in advance. In August it told investors that it expected to announce a chief financial officer succession plan before the wider leadership transition took effect on 1 November, and it has described the appointment as the next step in a multiyear leadership succession process that its board of directors approved unanimously. Keith Newton, chief executive officer, is due to become executive chairman of the board on the same day.
Tanner Newton joined Concentra in January 2025. His present remit spans corporate strategy, capital structure and allocation, real estate, treasury, procurement, corporate development, strategic pricing and investor relations, and the company said his direct work with equity and debt holders gives it continuity in investor relations through the handover. Before joining Concentra he spent more than a decade in private equity and investment banking, including senior investment leadership roles working alongside executive management teams and boards on growth and value creation. That work covered investment underwriting and transaction execution, advice on mergers and acquisitions and on capital markets activity, and support for strategic, financial and operational initiatives across portfolio companies. He holds a Master of Science in finance and bachelor degrees in accounting and business honors, summa cum laude, from Texas A&M University.
Announcing the appointment as the next stage of the succession, DiCanio said Newton is already shaping the company strategy and financial priorities, and has demonstrated sound judgment, strong financial acumen and a deep understanding of the business. He added that Newton knows the company people, operations and stakeholders, and is well positioned to help lead Concentra through its next phase of growth.
Newton said the company had a differentiated business model, meaningful opportunities for continued growth and a highly experienced leadership team, and that he looked forward to leading the finance organisation, supporting strategic initiatives, maintaining financial discipline and delivering lasting value for shareholders.
The job is a substantial one. Concentra describes itself as the largest provider of occupational health services in the United States by number of locations. As of 30 June 2026 it counted approximately 13,000 colleagues and affiliated physicians and clinicians, 633 occupational health centres, 415 onsite health clinics at employer worksites and a telemedicine service, supporting the care of about 54,000 patients on an average business day across 46 states and the District of Columbia.
That footprint makes the finance seat operationally heavy as well as financially technical. Occupational medicine is a volume business built on employer contracts, workers compensation claims and clinic level throughput, so capital allocation between new centres, onsite clinics at employer sites and corporate development sits directly with the chief financial officer. Concentra became a separately listed company after its spin off from Select Medical, which makes continuity with its equity and debt investors commercially valuable at a moment when both the chief executive seat and the finance seat change hands.
Capital returns are part of that picture. The board declared a cash dividend of 6.25 cents per share in August, payable to shareholders of record later that month. Newton inherits responsibility for balancing that payout, the company capital structure and its appetite for corporate development at the same time as a new chief executive settles in, a combination that will put his first full year in the role under close scrutiny from the investor base he already knows.
